Tadalafil

CAS No. 171596-29-5

Tadalafil( IC351, IC-351, IC 351, Tadalafil, Adcirca, Cialis )

Catalog No. M12614 CAS No. 171596-29-5

Tadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
10MG 30 In Stock
25MG 48 In Stock
50MG 68 In Stock
100MG 104 In Stock
200MG Get Quote In Stock
500MG 269 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tadalafil
  • Note
    Research use only, not for human use.
  • Brief Description
    Tadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM).
  • Description
    Tadalafil is a potent phosphodiesterase-5 (PDE5) inhibitor (IC50=1 nM); no inhibition on most of the other families of PDEs, with the exception of PDE11.Sexual Dysfunction Approved.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    IC351, IC-351, IC 351, Tadalafil, Adcirca, Cialis
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE5
  • Research Area
    Endocrinology
  • Indication
    Sexual Dysfunction

Chemical Information

  • CAS Number
    171596-29-5
  • Formula Weight
    389.404
  • Molecular Formula
    C22H19N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 52 mg/mL
  • SMILES
    O=C([C@@]1([H])CC2=C([C@@H](C3=CC(OCO4)=C4C=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O
  • Chemical Name
    Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Blount MA, et al. Mol Pharmacol, 2004, 66(1), 144-152. 2. Ring BJ, et al. Clin Pharmacol Ther, 2005, 77(1), 63-75.
molnova catalog
related products
  • FCPR03

    FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively.

  • BAY 2666605

    BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.

  • Trapidil

    Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor.